Literature DB >> 20570637

A population-based description of familial clustering of pancreatic cancer.

Brian H Shirts1, Randall W Burt, Sean J Mulvihill, Lisa A Cannon-Albright.   

Abstract

BACKGROUND & AIMS: Several familial pancreatic cancer syndromes have been identified. However, the prevalence of familial pancreatic cancers in the general population has not been well defined.
METHODS: We linked pancreatic cancer cases, identified through the Utah Cancer Registry, to the Utah Population Database, which contains genealogic data from Utah pioneers and their descendants. This database includes 1411 pancreatic adenocarcinoma cases with 3 or more generations of Utah pioneer genealogy. We examined the familial clustering of pancreatic cancer by evaluating the relative risk (RR) of pancreatic cancer among relatives of cases. We also used the genealogical index of familiality to test the hypothesis of no excess relatedness among pancreatic cancer cases.
RESULTS: The risk of pancreatic cancer was significantly increased in first-degree (RR, 1.84; 95% confidence interval [CI], 1.47-2.29; P < .0001) and second-degree (RR, 1.59; 95% CI, 1.31-2.91; P < .0001) relatives of individuals with pancreatic cancer. Analysis of case relatedness indicated significant excess relatedness for pancreatic cancer. More than 300 high-risk pedigrees were identified, with from 3-14 cases observed among descendants of pedigree founders.
CONCLUSIONS: This population-based study provides evidence for increased risk of pancreatic cancer among relatives of cases and for a significantly higher average relatedness among cases than expected. These observations support the role of genetic factors in pancreatic cancer. Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20570637     DOI: 10.1016/j.cgh.2010.05.012

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  14 in total

1.  Risk of associated conditions in relatives of subjects with interstitial cystitis.

Authors:  Kristina Allen-Brady; Peggy A Norton; Lisa Cannon-Albright
Journal:  Female Pelvic Med Reconstr Surg       Date:  2015 Mar-Apr       Impact factor: 2.091

Review 2.  Familial pancreatic cancer.

Authors:  Gloria M Petersen
Journal:  Semin Oncol       Date:  2016-09-22       Impact factor: 4.929

3.  Screening for pancreatic cancer in a high-risk cohort: an eight-year experience.

Authors:  Wigdan Al-Sukhni; Ayelet Borgida; Heidi Rothenmund; Spring Holter; Kara Semotiuk; Robert Grant; Stephanie Wilson; Malcolm Moore; Steven Narod; Kartik Jhaveri; Masoom A Haider; Steven Gallinger
Journal:  J Gastrointest Surg       Date:  2011-11-30       Impact factor: 3.452

Review 4.  Screening for pancreatic cancer: why, how, and who?

Authors:  Katherine E Poruk; Matthew A Firpo; Douglas G Adler; Sean J Mulvihill
Journal:  Ann Surg       Date:  2013-01       Impact factor: 12.969

5.  Familial pancreatic cancer risk: a population-based study in Utah.

Authors:  Divyanshoo R Kohli; Ken Robert Smith; Jathine Wong; Zhe Yu; Kenneth Boucher; Douglas O Faigel; Rahul Pannala; Randall W Burt; Karen Curtin; N Jewel Samadder
Journal:  J Gastroenterol       Date:  2019-06-25       Impact factor: 7.527

Review 6.  Familial Pancreatic Adenocarcinoma.

Authors:  Gloria M Petersen
Journal:  Hematol Oncol Clin North Am       Date:  2015-06-09       Impact factor: 3.722

7.  Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah.

Authors:  N Jewel Samadder; Ken Robert Smith; Jathine Wong; Heidi Hanson; Kenneth Boucher; Randall W Burt; Michael Charlton; Kathryn R Byrne; Juan F Gallegos-Orozco; Cathryn Koptiuch; Karen Curtin
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

8.  Molecular characteristics of pancreatic ductal adenocarcinoma.

Authors:  Niki A Ottenhof; Roeland F de Wilde; Anirban Maitra; Ralph H Hruban; G Johan A Offerhaus
Journal:  Patholog Res Int       Date:  2011-03-27

Review 9.  Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site.

Authors:  Frederick Albright; Craig Teerlink; Theresa L Werner; Lisa A Cannon-Albright
Journal:  BMC Cancer       Date:  2012-04-03       Impact factor: 4.430

10.  Strong evidence for a genetic contribution to late-onset Alzheimer's disease mortality: a population-based study.

Authors:  John S K Kauwe; Perry G Ridge; Norman L Foster; Lisa A Cannon-Albright
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.